Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Harish Chander

7PUBLICATIONS

3CO-AUTHORS

Molecular targetsPredictive and prognostic markers

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (7)

Sort by Publication Date:

|May 18, 2026

Current Landscape of Anti-HER2 Targeted Therapy in Breast Cancer: Challenges and Future Perspectives.

|Aug 05, 2022

High levels of unfolded protein response component CHAC1 associates with cancer progression signatures in malignant breast cancer tissues.

Vikrant Mehta, Prabhat Suman, Harish Chander

|Jun 21, 2022

Prognostic significance of CHAC1 expression in breast cancer.

Vikrant Mehta, Jaipal Meena, Harit Kasana

|Feb 08, 2022

Wild-type p53 suppresses formin-binding protein-17 (FBP17) to reduce invasion.

Prabhat Suman, Vikrant Mehta, Andrew W B Craig

|Jul 16, 2020

High formin binding protein 17 (FBP17) expression indicates poor differentiation and invasiveness of ductal carcinomas.

Prabhat Suman, Sarthak Mishra, Harish Chander

|Oct 17, 2018

Awakening the "guardian of genome": reactivation of mutant p53.

Akshay Binayke, Sarthak Mishra, Prabhat Suman

Pageof 2

Frequent Collaborators

1 joint publications

Pooja Bharali

1 joint publications

Vikrant Mehta

1 joint publications

Subhash Chand

Frequent Collaborators

1 joint publications

Pooja Bharali

1 joint publications

Vikrant Mehta

1 joint publications

Subhash Chand